In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding
Current pharmacological therapy against atrial fibrillation (AF), the most common cardiac arrhythmia, is limited by moderate efficacy and adverse side effects including ventricular proarrhythmia and organ toxicity. One way to circumvent the former is to target ion channels that are predominantly exp...
Main Authors: | Nicholas Ellinwood, Dobromir Dobrev, Stefano Morotti, Eleonora Grandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00799/full |
Similar Items
-
Effects of IKur blocker MK-0448 on human right atrial action potentials from pateints in sinus rhythm and in permanent atrial fibrillation.
by: Simone eLoose, et al.
Published: (2014-03-01) -
Evidences of the ultrarapid delayed rectifier potassium current (IKur) on pacemaker activity in sinoatrial and atrioventricular nodes of Rat
by: Mohammad reza Nikmaram, et al.
Published: (2008-09-01) -
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
by: Teruhiko Imamura, et al.
Published: (2020-10-01) -
Atrial fibrillation after cardiac surgery
by: Nair Suresh
Published: (2010-01-01) -
Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients
by: Hakan Gunes, et al.
Published: (2018-08-01)